New York, NY - (ACCESSWIRE) - 10/28/2013 - Equity Profile Report initiates its Health-care Active Stock Watch List adding Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Dendreon Corp. (NASDAQ:DNDN), Zogenix, Inc. (NASDAQ:ZGNX), and Novogen Limited (NASDAQ:NVGN)

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) a biopharmaceutical company that focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases is currently down (-17.19%) on 2,537,695 shares traded after Synta Pharma presented positive one-year follow-up results for the GALAXY-1 trial of Ganetespib in NSCLC. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is currently down (-56.82%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their Health-care Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Synta Pharmaceuticals Corp. (NASDAQ:SNTA)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=SNTA&SubId=AW

Dendreon Corp. (NASDAQ:DNDN) a biotechnology company that engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients is currently up (+13.83%) on 5,383,881 shares traded as Dendreon is to Host Conference Call on November 12 to Announce Third Quarter Financial Results. Dendreon Corp. (NASDAQ:DNDN) is currently up (+35.43%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their Health-care Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Dendreon Corp. (NASDAQ:DNDN)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=DNDN&SubId=AW

Zogenix, Inc. (NASDAQ:ZGNX) a pharmaceutical company that engages in the development and commercialization of products for the treatment of central nervous system disorders and pain is currently up (+9.18%) on 3,466,447 shares traded after ZOGENIX, INC. Filed SEC form 8-K, Other Events. Zogenix, Inc. (NASDAQ:ZGNX) is currently up (+209.91%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their Health-care Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Zogenix, Inc. (NASDAQ:ZGNX)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ZGNX&SubId=AW

Novogen Limited (NASDAQ:NVGN) operates as a pharmaceutical drug development company worldwide is currently up (+0.65%) on 198,083 shares traded. Novogen Limited (NASDAQ:NVGN) is currently up (+1254.17%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their Health-care Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Novogen Limited (NASDAQ:NVGN)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=NVGN&SubId=AW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.equityprofilereport.com/

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com